The novel approach of this peptide represents a exciting development in the handling of type 2 diabetes. Different to existing drugs, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatidepeptide986174.blogerus.com/64034232/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment